Fish & Richardson Names Betsy Flanagan as Managing Principal of Minneapolis Office

Fish & Richardson announced Betsy Flanagan has been named the managing principal of the Minneapolis office. She succeeds J. Patrick Finn III, Ph.D., who served in the role since 2015. The Minneapolis office houses over 30 IP attorneys and technology specialists, as well as the firm's administrative hub for support staff.

"I'm thrilled Betsy has agreed to take on the role of managing principal in Twin Cities," said John Adkisson, president and CEO of Fish. "I know she will continue cultivating our culture of innovation and teamwork and strive to ensure our team and clients receive the support and service they expect from Fish. I thank Patrick for his great work in this role and know he will continue leading our firm in other ways."

"It was my honor to serve our Twin Cities office for the past six years as we grew in so many ways with our space, our talent, and our client services," said Patrick. "Betsy is the right person to lead our exceptional, cutting-edge workplace that attracts top talent and allows us to build and maintain strong client partnerships."

Flanagan's practice focuses on complex patent litigation, with an emphasis on life sciences, biotechnology and pharmaceutical litigation, including Hatch-Waxman litigation. She has worked on a variety of technologies, including pharmaceutical formulations, glaucoma drugs, hair growth agents, dermal fillers, nucleosides, antibodies, biologics, and sleep apnea devices.

In addition to her strong office leadership, Flanagan has been widely recognized in Minnesota and nationally for her exceptional patent litigation work. Most recently, she was named the Litigation Practitioner of the Year for Minnesota by Managing Intellectual Property. For the last three years, Flanagan has been named one of the "Top 250 Women in Litigation" by Benchmark Litigation. In 2018, she was named an "Up & Coming Attorney" by Minnesota Lawyer and a "Women Worth Watching" award winner by Profiles in Diversity Journal. She has also been consistently named an "IP Star" by Managing Intellectual Property, a "Life Science Star" by LMG Life Sciences, and a Rising Star by Law360.